<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib73">
 <label>73</label>
 <element-citation publication-type="book" id="sref73">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <chapter-title>CanSino Biologics' Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials. TrialSiteNews</chapter-title>
  <year>2020</year>
  <publisher-name>Jiangsu Province Centers for Disease Control and Prevention</publisher-name>
  <comment>updated April 19th. Available from:</comment>
  <ext-link ext-link-type="uri" xlink:href="https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/" id="intref0150" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/</ext-link>
 </element-citation>
</ref>
